PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $187 | +466.7% | 84,697 | +549.0% | 0.02% | +466.7% |
| Q1 2023 | $33 | -53.5% | 13,050 | -65.7% | 0.00% | -50.0% |
| Q4 2022 | $71 | -99.9% | 38,060 | -23.1% | 0.01% | -14.3% |
| Q3 2022 | $127,000 | +33.7% | 49,510 | +1.1% | 0.01% | +16.7% |
| Q2 2022 | $95,000 | -41.7% | 48,987 | -10.7% | 0.01% | -25.0% |
| Q1 2022 | $163,000 | -35.1% | 54,868 | -2.0% | 0.01% | -42.9% |
| Q4 2021 | $251,000 | +18.4% | 55,972 | +28.4% | 0.01% | +16.7% |
| Q3 2021 | $212,000 | -8.2% | 43,596 | +28.8% | 0.01% | 0.0% |
| Q2 2021 | $231,000 | -53.2% | 33,846 | -57.1% | 0.01% | -65.7% |
| Q4 2020 | $494,000 | -59.5% | 78,859 | -65.0% | 0.04% | -66.3% |
| Q3 2020 | $1,219,000 | -26.1% | 225,409 | -28.7% | 0.10% | -31.6% |
| Q2 2020 | $1,650,000 | +48.8% | 316,053 | -10.2% | 0.15% | +90.0% |
| Q1 2020 | $1,109,000 | -34.3% | 351,941 | -15.9% | 0.08% | -32.2% |
| Q4 2019 | $1,687,000 | -9.5% | 418,681 | -3.0% | 0.12% | +1.7% |
| Q3 2019 | $1,865,000 | -42.4% | 431,724 | -46.8% | 0.12% | +54.7% |
| Q2 2019 | $3,240,000 | -17.6% | 811,882 | +10.7% | 0.08% | -29.9% |
| Q1 2019 | $3,930,000 | +140.5% | 733,296 | +130.2% | 0.11% | -12.3% |
| Q4 2018 | $1,634,000 | -61.7% | 318,518 | -27.6% | 0.12% | -47.2% |
| Q3 2018 | $4,265,000 | +46.0% | 439,726 | +53.5% | 0.23% | +45.3% |
| Q2 2018 | $2,922,000 | -12.4% | 286,500 | +11.7% | 0.16% | +19.5% |
| Q1 2018 | $3,335,000 | +2.6% | 256,500 | +41.3% | 0.13% | -33.5% |
| Q4 2017 | $3,249,000 | +34.1% | 181,500 | +88.1% | 0.20% | +73.9% |
| Q3 2017 | $2,422,000 | – | 96,500 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |